KMTS KESTRA MEDICAL TECHNOLOGIES...

Nasdaq www.kestramedical.com


$ 23.58 $ 1.34 (5.76 %)    

Friday, 17-Oct-2025 16:22:48 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 24.61
$ 22.96
$ 24.63 x 200
$ 26.88 x 1
$ 21.92 - $ 24.73
$ 13.25 - $ 27.71
312,949
na
1.26B
$ 0.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-12-2025 07-31-2025 10-Q
2 07-17-2025 04-30-2025 10-K
3 04-17-2025 01-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) raises FY2026 sales outlook from $85.000 million to $88.000 million vs $85.074 million estim...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of ...

Core News & Articles

Wells Fargo analyst Larry Biegelsen maintains Kestra Medical Techs (NASDAQ:KMTS) with a Overweight and lowers the price targ...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(1.15) per share which missed the analyst consensus estimate o...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) FY2026 Revenue expected to be more than $85.000M vs $82.972M Est

Core News & Articles

Kestra Medical Techs (NASDAQ: KMTS) sees FY2026 sales of $85.000 million vs $82.972 million analyst estimate.

Core News & Articles

Goldman Sachs analyst David Roman maintains Kestra Medical Techs (NASDAQ:KMTS) with a Neutral and lowers the price target fr...

Core News & Articles

Fiscal Year 2025 Revenue OutlookKestra expects revenue for fiscal year ending April 30, 2025 to be in the range of $58.0 millio...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(1.25) per share. This is a 5.93 percent decrease over losses ...

Core News & Articles

Wolfe Research analyst Mike Polark initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Outperform rating and ann...

Core News & Articles

Wells Fargo analyst Larry Biegelsen initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and an...

Core News & Articles

Stifel analyst Rick Wise initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Buy rating and announces Price Targ...

Core News & Articles

Goldman Sachs analyst David Roman initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Neutral rating and announc...

Core News & Articles

Piper Sandler analyst Matt O'Brien initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION